| __timestamp | Amneal Pharmaceuticals, Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 129764000 |
| Thursday, January 1, 2015 | 367054000 | 152008000 |
| Friday, January 1, 2016 | 420770000 | 209620000 |
| Sunday, January 1, 2017 | 507476000 | 241786000 |
| Monday, January 1, 2018 | 946588000 | 315264000 |
| Tuesday, January 1, 2019 | 1273376000 | 359466000 |
| Wednesday, January 1, 2020 | 1364130000 | 524272000 |
| Friday, January 1, 2021 | 1324696000 | 470515000 |
| Saturday, January 1, 2022 | 1427596000 | 483669000 |
| Sunday, January 1, 2023 | 1573042000 | 577065000 |
| Monday, January 1, 2024 | 580235000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, cost efficiency is paramount. BioMarin Pharmaceutical Inc. and Amneal Pharmaceuticals, Inc. have shown contrasting trends in their cost of revenue from 2014 to 2023. Amneal Pharmaceuticals has seen a staggering 368% increase in its cost of revenue, peaking at approximately $1.57 billion in 2023. This growth reflects their aggressive expansion and market penetration strategies. In contrast, BioMarin Pharmaceutical's cost of revenue grew by 345%, reaching around $577 million in the same period. This indicates a more measured approach, focusing on niche markets and specialized products. The data highlights the strategic differences between these two companies, with Amneal's broader market approach versus BioMarin's specialized focus. Understanding these trends provides valuable insights into their operational efficiencies and market strategies.
Cost of Revenue Comparison: Pfizer Inc. vs Amneal Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: BeiGene, Ltd. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs ADMA Biologics, Inc.
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs PTC Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Galapagos NV
Analyzing Cost of Revenue: Catalent, Inc. and Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. vs Perrigo Company plc: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Vericel Corporation
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.